Objective The close relationship between fatty liver and metabolic syndrome suggests that individuals with fatty liver may have multiple coronary risk factors. In the present study, we investigated the relationships among fatty liver, abdominal fat distribution, and coronary risk markers.
Introduction
Fatty liver and metabolic syndrome are induced by overnutrition; both conditions are closely related with each other (1) (2) (3) . Metabolic syndrome is a major risk factor for coronary artery disease (CAD) (4) (5) (6) (7) (8) (9) . The underlying abnormality in individuals with metabolic syndrome is thought to be related to visceral obesity (10) (11) (12) (13) . Therefore, fatty liver might be closely related to visceral fat accumulation and coronary risk factors; however the relationships among fatty liver, abdominal fat distribution, and the coronary risk factors remain poorly defined.
In the present study, we compared the coronary risk biomarkers and abdominal fat distribution (estimated by CT) between subjects with and without fatty liver. We measured the following coronary risk markers: plasma levels of glucose, lipids, apolipoproteins, remnant-like particle choles- terol (equivalent to triglyceride-rich lipoprotein remnants) (14, 15) , oxidized low-density lipoprotein (which is elevated in CAD) (16) (17) (18) , and adiponectin (an adipocytokine which is low in CAD) (19) (20) (21) .
Materials and Methods
This study was approved by the Ethics Committee of Tokai University Hospital and all subjects gave informed consent.
Subjects
Eighty-seven pairs of men and 42 pairs of women who were matched for age and body mass index (BMI) were selected from persons undergoing health screening and who received an abdominal fat examination in addition to standard examinations at the Health Evaluation and Promotion Center of Tokai University Hospital. The abdominal fat examination included an estimation of the visceral fat area and the subcutaneous fat area, a measurement of the plasma adiponectin level, and a measurement of homeostasis model assessment-insulin resistance (HOMA-IR). A total of 33 fatty liver-positive men, 41 fatty liver-negative men, and 20 pairs of women received an optional lipidology test in which the apolipoproteins and remnant-like particle cholesterol (RLP-C) were measured. The following subjects were excluded from the present study: subjects who were taking medications for the treatment of diabetes or hyperlipidemia; hypertensive subjects who were treated with β-blockers and diuretics; and subjects with secondary and familial hyperlipidemia.
Abdominal ultrasound examination
Abdominal ultrasound examinations were performed by expert technicians of Tokai University Hospital using a Xario SSA-660A apparatus (Toshiba, Tokyo, Japan). The diagnosis of fatty liver was made according to the abdominal ultrasonic examination manual of the Japan Ningen Dock Society.
Measurement of abdominal fat distribution
CT was performed and a single slice was obtained at the level of the umbilicus with a Somatoma Emission Duo scanner (Siemens, Munich, Germany). The data were then analyzed by computer using the FAT Scan ver. 4 software program (N2 System, Ashiya, Japan) to obtain estimates of the Men p value p value 1 Women visceral fat area, subcutaneous fat area, total fat area, and visceral fat area/subcutaneous fat area ratio (V/S ratio) (22) .
Laboratory tests
Liver function tests, plasma lipids, fasting plasma glucose (FPG), and hemoglobin A1c (HbA1c) were measured using an autoanalyzer as routine tests. Plasma apolipoproteins (apos) were measured by automated immunoturbidimetry (23) . The remnant-like particle cholesterol level [RLP-C; equivalent to triglyceride (TG)-rich lipoprotein remnants] was estimated by the immunoprecipitation method using monoclonal antibodies for apo AI and apo B-100 (24) . Oxidized low-density lipoprotein (ox-LDL) and adiponectin were measured by an enzyme-linked immunosorbent assay (ELISA) (25, 26) . The product of a reaction between lowdensity lipoprotein (LDL) and a monoclonal antibody for malondialdehyde (MDA)-modified LDL was defined as ox-LDL.
Statistical analysis
The data were expressed as median values (25th percentile, 75th percentile). The statistical differences between the subjects with and without fatty liver were determined by the Mann-Whitney U-test. The relationships between fatty liver and the study variables were assessed by a logistic regression analysis using the backward elimination method. The SPSS software program (IBM) was used for all of the statistical analyses.
Results
The background factors of the subjects are shown in Table 1. The abdominal circumference was significantly larger in women with fatty liver than in women without fatty liver. The plasma alanine aminotransferase (ALT) and γGTP levels were significantly higher in both men and women with fatty liver than in those without fatty liver. The visceral fat area was larger in men with fatty liver than in men without fatty liver, but there was no significant difference in women. The visceral fat area (V) / subcutaneous fat area (S) ratio was significantly higher in both men and women with fatty liver than in those without fatty liver. The alcohol intake and smoking rate were very low in the women and did not differ to a statistically significant extent between the fatty liverpositive and fatty liver-negative subjects of either sex. The prevalence of metabolic syndrome is shown in Table 1 . The The coronary risk markers of the subjects with and without fatty liver are compared in Table 2 . The plasma levels of TG and LDL-cholesterol (LDL-C) were significantly higher, while the high-density lipoprotein cholesterol (HDL-C) levels were lower, in both men and women with fatty liver than in those without fatty liver. The plasma levels of RLP-C, apo B, and ox-LDL were significantly higher in men with fatty liver than in men without fatty liver; however, this difference was not observed in women. The FPG level was significantly higher in women with fatty liver than in women without fatty liver, but not in men. The HOMA-IR level was significantly higher, while the plasma adiponectin level was significantly lower in both males and females subjects with fatty liver than in those without fatty liver.
The number of female subjects was too small to perform a logistic regression analysis. Thus, a logistic regression analysis was only performed for the male subjects. The odds ratios for each of the factors that were investigated are shown in Table 3 . The levels of ALT, RLP-C, apo B, diastolic blood pressure, and HOMA-IR, as well as the visceral fat area, were significantly higher in men with fatty liver than in men without fatty liver. However, the levels of plasma TG, ox-LDL, and fasting plasma glucose did not differ between men with fatty liver and those without fatty liver. Furthermore, although the apo AI level was significantly lower in men with fatty liver than in men without fatty liver, the plasma HDL-C and adiponectin levels did not differ to a statistically significant extent.
Discussion
The present study was associated with a major limitation in that the optional examinations were voluntary. Thus, the selection of subjects was not random. A second limitation is that the subjects' information was obtained from a questionnaire; however, we made an effort to ensure that many of the questionnaire items were easy to answer.
In the present study, we compared the obesity-related markers, abdominal fat distribution, (examined by CT), and coronary risk markers of subjects with and without fatty liver. When BMI was not matched, the subjects with fatty liver had a higher BMI and a larger waist circumference than those without fatty liver, while the visceral fat area and subcutaneous fat area were larger in subjects with fatty liver than in those without fatty liver. Accordingly, the BMI was matched to minimize the influence of obesity in the present study. Fatty liver is closely related to metabolic syndrome (1-3, 9) . Individuals with fatty liver could therefore have similar coronary risk factors to individuals with metabolic syndrome (1-3, 18-21, 27 ). The present study showed that the TG, LDL-C, and HOMA-IR levels were higher, while the HDL-C and adiponectin levels were lower in both men and women with fatty liver than in those without fatty liver. High HOMA-IR levels mainly occurred due to high plasma insulin levels. However, the RLP-C, apo B, and ox-LDL levels were also significantly higher in men with fatty liver than in men without fatty liver; these differences were not found in women. Furthermore, the visceral fat area was larger in men with fatty liver than in men without fatty liver -but not in women. The coronary risk factors associated with fatty liver were therefore different in the male and female subjects, and men with fatty liver had a higher risk of coronary disease than women with fatty liver.
In the male subjects, a logistic regression analysis revealed that fatty liver was closely related with the elevation of RLP-C, apo B, diastolic blood pressure, HOMA-IR, and visceral fat area. These coronary risk markers therefore seemed to be closely associated with fatty liver in men. However, while an increase in the visceral fat area was associated with fatty liver, a decrease in adiponectin was not. In men, fatty liver was also closely related to a decrease in the apo AI level.
Conclusion
Both men and women with fatty liver had reduced insulin sensitivity, low HDL-C and adiponectin levels, and high TG and LDL-C levels. High plasma levels of RLP-C, apo B, and ox-LDL and low levels of plasma apo AI were coronary risk markers that were closely related to the presence of fatty liver in men. Furthermore, men with fatty liver had a higher risk of coronary disease than women with fatty liver.
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